NASDAQ · Medical - Devices

NMTC (NMTC) Stock

$1.69 -0.59% NASDAQ: NMTC Healthcare

Valuation

MetricValue
Price$1.69
Market Cap$14.71M
P/E Ratio-8.52
P/B Ratio5.66
P/S Ratio3.73
EPS (TTM)$-0.54
52-Week High$6.96
52-Week Low$1.69
Dividend Yield0.00%

Financials & Margins

MetricValue
ROE-57.14%
ROA-36.36%
ROCE-57.14%
Gross Margin-33.33%
Operating Margin-33.33%
Net Margin-68.34%
Debt/Equity0.04
Current Ratio5.00

Annual Financials (USD)

Metric20212022202320242025
Revenue$0$0$2.0M$3.0M$12.0M
Operating Profit$-10.0M$-10.0M$-12.0M$-12.0M$-4.0M
Net Profit$-10.0M$-10.0M$-12.0M$-12.0M$-4.0M
EPS$-5.58$-3.78$-3.90$-2.76$-0.54
Op Margin-5735.9%-5860.1%-612.3%-344.3%-34.9%

Balance Sheet (USD)

Metric20212022202320242025
Total Assets$8.0M$13.0M$8.0M$5.0M$11.0M
Total Liabilities$1.0M$3.0M$2.0M$5.0M$4.0M
Cash$7.0M$8.0M$5.0M$1.0M$7.0M
Borrowings$0$0$0$0$0

Latest News

NeuroOne(R) Expands Drug Delivery Program Through Collaboration on Pediatric Brain Cancer Clinical Trial NewMediaWire · Jul 16, 2026 NeuroOne(R) Added to Russell Microcap(R) Index NewMediaWire · Jun 29, 2026 NeuroOne(R) Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) NewMediaWire · Jun 25, 2026 NeuroOne(R) Announces Preliminary Inclusion in Russell Microcap(R) Index NewMediaWire · Jun 16, 2026 NeuroOne(R) to Present at the Planet MicroCap Las Vegas 2026 Conference Wednesday, June 17, 2026 at 12:00 p.m. Pacific Time NewMediaWire · Jun 8, 2026

Cash Flow (USD)

Metric20212022202320242025
Operating Cash Flow$-9.0M$-8.0M$-13.0M$-11.0M$-3.0M
Investing Cash Flow$0$-4.0M$2.0M$0$0
Financing Cash Flow$3.0M$-1.0M$-1.0M$1.0M$-2.0M
Net Cash Flow$3.0M$1.0M$-3.0M$-4.0M$5.0M
Free Cash Flow$-9.0M$-8.0M$-13.0M$-11.0M$-3.0M

Valuation & Return Ratios

MetricValue
PEG Ratio—
EV / EBITDA—
FCF Yield-20.85%
Quick Ratio3.26
Interest Coverage—
Return 1Y-40.66%
Return 3Y-78.98%
Return 5Y-92.57%

Ownership

Insiders Held26.40%
Institutions Held22.69%
Institutions Float Held30.82%
Institutional HolderSharesReport Date
Bleichroeder LP666,6682026-03-31
Bard Associates Inc.306,7502026-03-31
Perkins Capital Management, Inc.245,5002026-03-31
Vanguard Capital Management LLC232,8892026-03-31
Renaissance Technologies, LLC109,2412026-03-31

Peer Comparison

TickerPriceChangeP/EMarket CapDiv Yield
ATHEAlterity Therapeutics Limited $4.70 -5.62% -6.89 $42.60M 0.00%
BDMD $1.07 +1.42% -1.68 $45.16M 0.00%
CTSO $0.35 -4.32% -3.62 $22.25M 0.00%
ECORelectroCore, Inc. $6.02 -2.75% -3.42 $49.94M 0.00%
HYPD $2.64 -0.75% -0.40 $13.17M 0.00%

About NMTC

NMTC is led by CEO David A. Rosa, employs 17 people, headquartered in US, publicly traded since 2018.

NMTC stock trades at $1.69 with a market capitalization of $14.71M. The stock is valued at a price-to-earnings (P/E) ratio of -8.52, price-to-book of 5.66, price-to-sales of 3.73. Over the past 52 weeks the stock has ranged between $1.69 and $6.96, and currently trades 75.7% below its 52-week high.

On profitability, NMTC generates a return on equity (ROE) of -57.14%, return on capital employed of -57.14%, an operating margin of -33.33%, a net profit margin of -68.34%.

Related Healthcare Stocks

LLY Drug Manufacturers - General $1185.71 -0.52% JNJ Drug Manufacturers - General $259.24 +0.88% ABBV Drug Manufacturers - General $246.04 +0.89% UNH Medical - Healthcare Plans $407.08 +0.77% MRK Drug Manufacturers - General $128.57 +0.16% NVS Drug Manufacturers - General $158.83 -0.64% NVO Biotechnology $51.58 +1.22% TMO Medical - Diagnostics & Research $594.00 +2.41% AMGN Drug Manufacturers - General $387.64 -1.39% ABT Medical - Devices $108.03 +0.70% GILD Drug Manufacturers - General $132.73 -1.18% PFE Drug Manufacturers - General $26.74 +2.06%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)JPMorgan (JPM)Visa (V)

Screens featuring this stock

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksNasdaq High ROE StocksAll stock screens
Run Stock Screener Investing Guides